Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7627-7632

  Cohen, Jeffrey I ^a,b   Lekstrom, Kristen ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLONY STIMULATING FACTOR RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; COMBINED IMMUNODEFICIENCY; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; IMMUNE RESPONSE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINATION;

EID: 0032815844     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7627-7632.1999     Document Type: Article

References (45)

1. Ahn, K., A. Gruhler, B. Galochia, T. R. Jones, E. J. H. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
2. Ahuja, S. K., and P. M. Murphy. 1993. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 268: 20691-20694.
3. Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350.
4. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
5. Birkenbach, M., K. Josefsen, R. Yalamanchili, G. Lenoir, and E. Kieff. 1993. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67:2209-2220.
6. Biron, C. A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24-34.
7. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
8. Cheeseman, S. H., W. Henle, R. H. Rubin, N. E. Tolkoff-Rubin, B. Cosimi, K. Cantell, S. Winkle, J. T. Herrin, P. H. Black, P. S. Russell, and M. S. Hirsch. 1980. Epstein-Barr virus infection in renal transplant recipients: effects of antithymocyte globulin and interferon. Ann. Intern. Med. 93:39-42.
9. Cohen, J. I. 1998. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J. Infect. Dis. 177:1390-1393.
10. Cohen, J. I., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545-2554.
11. Cohen, J. I., G. R. Picchio, and D. E. Mosier. 1992. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J. Virol. 66:7555-7559.
12. Cohen, J. I., and K. Lekstrom. Unpublished data.
13. Dambaugh, T., C. Beisel, M. Hummel, W. King, S. Fennewald, A. Cheung, M. Heller, N. Raab-Traub, and E. Kieff. 1980. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc. Natl. Acad. Sci. USA 77:2999-3003.
14. Gao, J.-L., and P. M. Murphy. 1994. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 269:28539-28542.
15. Garner, J. G., M. S. Hirsch, and R. T. Schooley. 1984. Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha. Infect. Immun. 43:920-924.
16. Gilbert, M. J., S. R. Riddell, B. Plachter, and P. D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722.
17. Hasler, F., H. G. Bluestein, N. J. Zvaifler, and L. B. Epstein. 1983. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J. Exp. Med. 157:173-188.
18. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus protein turns off the TAP to evade host immunity. Nature 375:411-415.
19. Hsu, D.-H., R. deWaal Malefyt, D. F. Fiorentino, M.-N. Dang, P. Vieira, J. deVries, H. Spits, T. R. Mosmann, and K. W. Moore. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832.
20. Joncas, J., Y. Monczak, F. Gibu, C. Alfieri, A. Bonin, G. Ahronheim, and G. Rivard. 1989. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J. Med. Virol. 28:110-117.
21. Levitskaya, J., A. Shapiro, A. Leonchiks, A. Ciechanover, and M. G. Massucci. 1997. Inhibition of ubiquitin/proteosome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616-12621.
22. Lin, J.-C., Z.-X. Zhang, T.-C. Chou, I. Sim, and J. S. Pagano. 1989. Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3′-azido-3′-deoxythymidine. J. Infect. Dis. 159:248-254.
23. Lindahl, P., I. Gresser, P. Leary, and M. Tovey. 1976. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc. Natl. Acad. Sci. USA 73:1284-1287.
24. Masucci, M. G., M. T. Bejarno, G. Masucci, and E. Klein. 1983. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected cells. Cell. Immunol. 76:311-321.
25. Moore, P. S., C. Bashoff, R. A. Weiss, and Y. Chang. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
26. Prabhu, A., M. Warwick, and A. Mathur. 1996. Decreased levels of circulating interferon-alpha and increased sCD23 in patients with acute infectious mononucleosis. Viral Immunol. 9:45-50.
27. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517.
28. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
29. Roth, P., and E. R. Stanley. 1992. The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181:141-167.
30. Russo, J. J., R. A. Bohenzky, M.-C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 93:14862-14867.
31. Shapiro, R. S., K. McClain, G. Frizzera, K. J. Gajl-Peczalska, J. H. Kersey, B. R. Blazar, D. C. Arthur, D. F. Patton, J. S. Greenberg, B. Burke, N. K. C. Ramsay, P. McGlavew, and A. H. Filipovich. 1988. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234-1243.
32. Strockbine, L. D., J. I. Cohen, T. Farrah, S. D. Lyman, F. Wagener, R. F. DuBose, R. I. Armitage, and M. K. Spriggs. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
33. Stuart, A. D., J. P. Stewart, J. R. Arrand, and M. Mackett. 1995. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11:1711-1719.
34. Sullivan, J. L., K. S. Byron, F. E. Brewster, and D. T. Purtillo. 1980. Deficient natural killer cell activity in the X-linked lymphoproliferative syndrome. Science 210:543-544.
35. Swaminathan, S., R. Hesselton, J. Sullivan, and E. Kieff. 1993. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol. 67:7406-7413.
36. Tanner, J. E., C. Alfieri, T. A. Chatila, and F. Diaz-Mitoma. 1996. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. J. Virol. 70:570-575.
37. Tanner, J. E., M. X. Wei, C. Alfieri, A. Ahmad, P. Taylor, T. Ooka, and J. Menezes. 1997. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHl A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. J. Infect. Dis. 175: 38-46.
38. Tomkinson, B., E. Robertson, R. Yalamanchili, R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus recombinants from overlapping cosmid fragments. J. Virol. 67:7298-7306.
39. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950.
40. Warren, M. K., and P. Ralph. 1986. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J. Immunol. 137:2281-2285.
41. Wei, M. X., J.-C. Moulin, G. Decaussin, F. Berger, and T. Ooka. 1994. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res. 54:1843-1848.
42. Wei, M. X., M. de Turenne-Tessier, G. Decaussin, G. Benet, and T. Ooka. 1997. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 14:3073-3081.
43. Wei, M. X., and T. Ooka. 1989. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J. 8:2897-2903.
44. Yao, Z., W. C. Fanslow, M. F. Seldin, A.-M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811-821.
45. Zhang, C. X., G. Decaussin, J. Daillie, and T. Ooka. 1988. Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J. Virol. 62:1862-1869.